DISPERAZOL PHARMA LIMITED
Significant control: Prof Michael Givskov (25–50%), Carl Jorg Michael Graz (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Disperazol Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Disperazol Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
DISPERAZOL PHARMA LIMITED is an active private limited company (company number 17304080) incorporated on 26 June 2026, registered in Merthyr Tydfil. Its registered activity is research and experimental development on biotechnology (SIC 72110). No accounts have been filed yet; the first accounts are due by 26 March 2028.
There are 2,418 companies in research and experimental development on biotechnology in the UK with filed accounts; the median reports net assets of £1,000 and is 7 years old.
Ownership and control
- Prof Michael Givskov
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Carl Jorg Michael Graz
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 26 June 2026under 1 yr ago
- First accounts due
- 26 March 2028in 516 days
- Confirmation statement due
- 10 July 2027in 256 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- No Accounts Filed
Financials
No accounts filed yet. The first accounts are due by 26 March 2028; this page updates when they are filed.
Timeline
- First accounts duein 516 days
- Confirmation statement duein 256 days
- Incorporated
Similar companies in Cardiff
- VERITAS RESEARCH LTDTreorchy · inc. Jun 2026
- MIRARE THERAPEUTICS LTDCardiff · inc. Jul 2026
- AR & R RESEARCH ENTERPRISES LTDNewport · inc. Apr 2026
- GENUM LTDCardiff · inc. Dec 2025
- PENDRAGON PEPTIDES LTDCardiff · inc. Nov 2025
- XEMX LTDCardiff · inc. Jul 2025
All companies incorporated on 26 June 2026 · in Jun 2026.
Reminders for DISPERAZOL PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.